Monitor for any future conversion to SC 13D or increased stake activity, though the passive certification suggests no activist intent. The stake size is moderate and unlikely to drive near-term price action.
Price Chart
Executive Summary
AdvisorShares Trust disclosed a 6.78% passive stake in Psyence Biomedical Ltd. via a new Schedule 13G filing, holding 258,538 common shares as of September 30, 2026. This is a new position from a registered investment adviser, indicating passive investment intent with no plans to influence management.
Key Financial Metrics
Key Facts
- AdvisorShares Trust filed a new Schedule 13G disclosing beneficial ownership of 258,538 common shares of Psyence Biomedical Ltd.
- The stake represents 6.78% of shares outstanding as of September 30, 2026.
- The filing certifies the securities were acquired in the ordinary course of business and not to change or influence control.
- This is a new position; the prior SC 13G/A was filed by Jeffrey David Weiner, a different filer.
Financial Impact
6.78% passive stake valued at approximately $258,538 based on share count (no per-share price disclosed in filing).
Risk Factors
- AdvisorShares could increase or decrease the position without further disclosure until crossing the next threshold.
- The prior filer (Jeffrey David Weiner) reduced or exited their position, as no current filing from them is present.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0000929638-26-003844 |
| Document: 0000929638-26-003844-index.html | 0000929638-26-003844 |
| Document: 0000929638-26-003844.txt | 0000929638-26-003844 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 6d ago | 6-K | $4.52 $4.12 | ▼ −8.85% | ▼ −7.67% | $3.13 (−30.64%) |
Oct 15, 2026 12d ago | SC 13D/A | $4.32 $4.22 | ▼ −2.31% | ▼ −1.21% | $3.13 (−27.43%) |
Oct 5, 2026 22d ago | SC 13G | $5.08 $5.02 | ▼ −1.18% | ▼ −1.73% | $3.13 (−38.29%) |
Oct 5, 2026 22d ago | 6-K | $5.08 $5.02 | ▼ −1.18% | ▼ −1.73% | $3.13 (−38.29%) |
Oct 5, 2026 22d ago | Press Release | $5.08 $5.02 | ▼ −1.18% | ▼ −1.73% | $3.13 (−38.29%) |
Sep 28, 2026 29d ago | 6-K | $5.67 $5.43 | ▼ −4.15% | ▼ −3.96% | $3.13 (−44.66%) |
Sep 28, 2026 29d ago | Press Release | $5.67 $5.43 | ▼ −4.15% | ▼ −3.96% | $3.13 (−44.66%) |
Sep 23, 2026 4w ago | 6-K | $6.31 $5.86 | ▲ +7.13% | ▲ +7.05% | $3.13 (+50.32%) |
Sep 14, 2026 6w ago | 6-K | $6.00 $6.07 | ▲ +1.17% | ▲ +1.63% | $3.13 (−47.75%) |
Sep 2, 2026 7w ago | EFFECT | $4.37 $4.43 | ▲ +1.37% | ▲ +0.33% | $3.13 (−28.26%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers